Esther Wagena

Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity

Bettina Weigelin, Annemieke Th. den Boer, Esther Wagena et al. · Nature Communications · 2021 · 226 citations · Full text

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb

Bettina Weigelin, Elixabet Bolaños, Álvaro Teijeira et al. · Proceedings of the National Academy of Sciences · 2015 · 108 citations · Full text

Baculovirus complementation restores a novel<i>NDUFAF2</i>mutation causing complex I deficiency

Saskia J.G. Hoefs, Cindy E. Dieteren, Richard J. Rodenburg et al. · Human Mutation · 2009 · 49 citations · Full text

Genetics, Viral Pathogenesis, Molecular Biology +18

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells

Jolien M.R. Van der Meer, Ralph J. A. Maas, Karolin Guldevall et al. · Cancer Immunology Immunotherapy · 2020 · 43 citations · Full text

Vivo Half-life, Immunology, Immune Regulation +21

Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma

Julia Odenthal, Mark Rijpkema, Desirée L. Bos et al. · Scientific Reports · 2018 · 32 citations · Full text